Trials / Completed
CompletedNCT00073489
A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)
A Pilot Trial of OSI-461 in Patients With Chronic Lymphocytic Leukemia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 23 (planned)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to evaluate the safety and efficacy of OSI-461 in CLL patients.
Detailed description
The primary objective of this study is to determine the activity of OSI-461 given twice daily orally in previously untreated CLL patients. The secondary objective is to evaluate the safety profile of OSI-461 in this patient population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OSI-461 |
Timeline
- Start date
- 2001-05-01
- Completion
- 2003-12-01
- First posted
- 2003-11-25
- Last updated
- 2011-10-17
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00073489. Inclusion in this directory is not an endorsement.